BioLife Solutions, Inc. reported past fourth-quarter 2025 sales of US$24.76 million versus US$20.72 million a year earlier, with full-year 2025 revenue of US$96.21 million and a reduced net loss of ...

Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations ...

BioLife Solutions (NASDAQ:BLFS) reported fourth-quarter and full-year 2025 results highlighting double-digit growth, ...

BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2025 Earnings Call Transcript February 26, 2026 BioLife Solutions, Inc. beats ...

BioLife Solns (NASDAQ:BLFS) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of ...

Q4 2025 earnings call recap: 2026 revenue guidance, margin outlook, CGT demand drivers, and QKine partnership.

In the preceding three months, 4 analysts have released ratings for BioLife Solns (NASDAQ:BLFS), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their ...

In a viral TikTok, a woman alleges that BioLife, a prominent plasma donation center, wrongfully diagnosed her with Hepatitis B, leading to a lifetime ban on donating plasma. The video, posted by Kelly ...

A blood plasma center that opened in Moorhead in April is drawing more donors than anticipated. When BioLife Plasma Services opened at 2960 12th St. S., it took in 250 donors a week. Now the center ...

BioLife Plasma, a plasma donation center, opened its 200th U.S. location and first location in Pearland on March 25. The new plasma service center located at 3020 Kirby Drive is part of the ...

BioLife Solutions (BLFS-2.70%) is starting the week with a bang. On Monday morning, the company announced it has signed a definitive agreement to purchase privately held SciSafe. The price is $30 ...